Previous studies found Hawaiians and Asian-Americans/Pacific Islanders to be independently at increased risk for nontuberculous mycobacterial pulmonary disease (NTMPD) and tuberculosis (TB). To better understand NTM infection and TB risk patterns in Hawaii, USA, we evaluated data on a cohort of patients in Hawaii for 2005-2013. Period prevalence of NTMPD was highest among Japanese, Chinese, and Vietnamese patients (>300/100,000 persons) and lowest among Native Hawaiians and Other Pacific Islanders (50/100,000). Japanese patients were twice as likely as all other racial/ethnic groups to have Mycobacterium abscessus isolated (adjusted odds ratio 2.0, 95% CI 1.2-3.2) but were not at increased risk for infection with other mycobacteria species. In contrast, incidence of TB was stable and was lowest among Japanese patients (no cases) and highest among Filipino, Korean, and Vietnamese patients (>50/100,000). Substantial differences exist in the epidemiology of NTMPD by race/ethnicity, Patients receiving anti-tumor necrosis factor-α (anti-TNF-α) therapy are at increased risk for tuberculosis and other granulomatous diseases, but little is known about illness caused by nontuberculous mycobacteria (NTM) in this setting. We reviewed the US Food and Drug Administration MedWatch database for reports of NTM disease in patients receiving anti-TNF-α therapy. Of 239 reports collected, 105 (44%) met NTM disease criteria. Median age was 62 years; the majority of patients (66, 65%) were female, and most (73, 70%) had rheumatoid arthritis. NTM infections were associated with infliximab (n = 73), etanercept (n = 25), and adalimumab (n = 7); most patients were taking prednisone (n = 68, 65%) or methotrexate (n = 58, 55%) concurrently. Mycobacteria avium (n = 52, 50%) was most commonly implicated, and 9 patients (9%) had died at the time their infections were reported. A high rate of extrapulmonary manifestations (n = 46, 44%) was also reported. TY - JOUR. T1 - Infectious post-LASIK crystalline keratopathy caused by nontuberculous mycobacteria [2] (multiple letters). AU - Yatziv, Yossi. AU - Varssano, David. AU - Lazar, Moshe. AU - Alvarenga, Lenio. AU - De Freitas, Denise. AU - Luísa Hofling-Lima, Ana. AU - Belfort, Rubens. AU - Sampaio, Jorge. AU - Sousa, Luciene. AU - Yu, Maria. AU - Mannis, Mark. PY - 2003/3. Y1 - 2003/3. UR - http://www.scopus.com/inward/record.url?scp=0037363492&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=0037363492&partnerID=8YFLogxK. M3 - Article. C2 - 12605062. AN - SCOPUS:0037363492. VL - 22. SP - 188. JO - Cornea. JF - Cornea. SN - 0277-3740. IS - 2. ER - ... emergence and spread of multidrug resistance. Authors: Manson, A.L., Cohen, K.A., Abeel, T., Velayati, A.A., Farnia, P., et al.. Journal : Nature Genetics. 3. Association of interferon-γ receptor-1 gene polymorphism with nontuberculous mycobacterial lung infection among Iranian patients with pulmonary disease. Authors: Farnia, P., Ghanavi, J., Saif, S., Farnia, P., Velayati, A.A.. Journal : American Journal of Tropical Medicine and Hygiene. 4. Comparison between pulmonary and extrapulmonary tuberculosis in adolescents. Authors: Lotfian, F., Lotfian, G., Bolursaz, M.R., Tabarsi, P., Velayati, A.. Journal : Archives of Pediatric Infectious Diseases. 5. Low bone mineral density and associated factors in patients with cystic fibrosis: A cross-sectional study. Authors: Nodoushan, A.J., Golzar, A., Hassanzad, M., Sayedi, S.J., Velayati, A.. Journal : International Journal of Pediatrics. 6. Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital. Authors: ... Introduction: The epidemiology of nontuberculous mycobacteria (NTM) disease remains largely unknown in Greece.. Methods: We investigated the characteristics of patients under treatment for NTM disease for the first time in Greece, for the time period 2004-2013.. Results: Out of 58 cases (27 men and 31 women, mean age±sd: 58.93±12.55 years), one patient suffered from skin (M. marinum) and the rest form pulmonary disease. Fifty patients were of Greek origin and 8 were immigrants. M. avium complex (MAC) was the leading cause of NTM disease (35 cases, 60.34%: M. avium 16, M. intracellulare 16), M. kansasii ranked second with 8 cases (13.79%) whereas RGM presented with a relative frequency of 10.34%. The rest of NTM comprised an additional 15.53% (4 M. malmoense, 2 M. xenopi, 1 M. celatum, 1 M.lentiflavium, 1 M. marinum). Cavitation was present in 40 patients (69%) and 20 nodular bronchiectatic pattern in 18 (31%). All patients were HIV negative, 30 suffered from previously known bronchiectases, 16 ... Low temperature domestic washing (i.e. < 40 °C) may be regarded as low-hygienic because thermal inactivation of microorganisms does not occur. Thus other means (i.e. bleaching agents) must be considered to compensate for low temperature and to achieve hygienic effects. In this study the biocidal activity of common bleaching systems as used in heavy duty detergents was examined using standard suspension test. The bleaching agents used for the tests were perborate, percarbonate, and phthalimodoperoxocaproic acid, as bleaching activators for low temperature bleaching tetraactetylethylenediamine (TAED) and nonanoyloxybenzenesulfonate (NOBS) were used. The bactericidal, fungicidal and virucidal properties of bleaching systems in question were determined on selected microorganisms (Enterococcus faecium, Escherichia coli, Staphylococcus aureus, Mycobacterium terrae, Candida albicans, Aspergillus niger and coliphages [phix174 and MS2]). The effects of temperature, pH and presence of soil on the ... Ahn, CH, Lowell, JR, Ahn, SS, Ahn, S, Hurst, GA. "Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs". Rev Infect Dis. vol. 3. 1981. pp. 1028-34. (An evaluation of 256 patients with pulmonary M. kansasii infection. All of the 115 patients who received treatment that included rifampin had sputum conversion within 4 months. However, for regimens that did not include rifampin, 127 (90%) of 141 had conversion (p,0.01). There were no relapses reported in those who received rifampin versus 4/59 (7%) who did not receive rifampin.). Ahn, CH, Lowell, JR, Ahn, SS, Ahn, SI, Hurst, GA. "Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii". Am Rev Respir Dis. vol. 128. 1983. pp. 1048-50. (Forty patients with pulmonary M. kansasii were treated with rifampin, isoniazid, and ethambutol for 12 months (plus streptomycin twice weekly for the first 3 months): 1/40 (2.5%) relapsed 6 months after completion of therapy.). "First randomised ... In the current study, six out of 139 CF patients, suffering from NTM disease, mainly due to M. abscessus, are described. It was found that ABPA and systemic steroid therapy were associated with this complication. As this is a rare condition, the series of patients with NTM reported in this study is small, and, therefore, the statistical analysis must remain weak at best. Nevertheless, it is believed that this experience underlines an important and challenging clinical aspect in CF.. NTM infection appears to be an emerging disease. A clinical microbiology laboratory in Israel reported that NTM and, in particular, the species M. chelonae (of which M. abscessus was previously considered a subspecies), M. fortuitum and M. simiae are increasing in incidence 19. During 1996-1999, 135 specimens from 9,391 patients cultured positive for NTM. Of these, five patients had M. chelonae. Between 2000 and 2003, 364 out of 9,031 patients were culture positive for NTM (p,0.0001) and, of these, 51 had M. chelonae ... SANCHO CHINESTA, J. y CARRION VALERO, F.. Lung infection for Mycobacterium kansaii and carcinoma of the lung synchronous. An. Med. Interna (Madrid) [online]. 2002, vol.19, n.4, pp.38-40. ISSN 0212-7199.. The association of lung tuberculosis and carcinoma of the lung is very well-known, although it is exceptional the synchronous presentation of lung infection for nontuberculous mycobacteria and lung carcinoma. We present the case of a 41 yearold male, smoker, with antecedents of lung tuberculosis in the adolescence and chronic liver disease for virus B and C that he presents fever, hoarseness and loss of 4 kg of weight of a month of evolution. The CT scan of the chest revealed a lung mass in left apex with pneumonitis, tumor invading chest wall and mediastinal lymph node enlargement. The biopsy of a supraclavicular node showed metastasisof squamous carcinoma, while in the sputum was isolated Mycobacterium kansasii seneitive to rifampin and ethambutol. HIV was negative. The possible mechanisms of ... Mycobacterium fortuitum is a nontuberculous species of the phylum actinobacteria (Gram-positive bacteria with high guanine and cytosine content, one of the dominant phyla of all bacteria), belonging to the genus mycobacterium. Mycobacterium fortuitum is a fast-growing species that can cause infections. The term "fast growing" is a reference to a growth rate of 3 or 4 days, when compared to other Mycobacteria that may take weeks to grow out on laboratory media. Pulmonary infections of M. fortuitum are uncommon, but Mycobacterium fortuitum can cause local skin disease, osteomyelitis (inflammation of the bone), joint infections and infections of the eye after trauma. Mycobacterium fortuitum has a worldwide distribution and can be found in natural and processed water, sewage, and dirt. Bacteria classified as Mycobacteria, include the causative agents for tuberculosis and leprosy. Mycobacteria are sometimes referred to as "acid-fast bacteria," a term referencing their response to a laboratory ... NIH Rare Diseases : 50 mycobacterium fortuitum is a bacteria that can cause infections of many areas of the body including the skin, lymph nodes, and joints. it belongs to a group of bacteria, known as nontuberculous mycobacterium, as it is different from the mycobacterium that causes tuberculosis. it can be found in natural and processed water, sewage, and dirt. healthy people usually do not get mycobacterium fortuitum infections; however, they may occur after surgery, in people with an impaired immune system, or after exposure to a contaminated medical device (such as an endoscope). it is uncommon for this condition to cause lung disease, but mycobacterium fortuitum infection can lead to skin disease, osteomyelitis (inflammation of the bone), joint infections, and eye disease. the signs and symptoms of infection differ depending on the infection site. treatment also depends on the site of the infection, but usually includes prolonged use of antibiotics. last updated: 2/22/2017 ... In the United States, the incidence and prevalence of pulmonary infection with NTM, mostly in association with bronchiectasis (Chap. 312), have for many years been several-fold higher than the corresponding figures for tuberculosis, and rates of the former are increasing among the elderly. Among patients with cystic fibrosis, who often have bronchiectasis, rates of clinical infection with NTM range from 3% to 15%, with even higher rates among older patients. Although NTM may be recovered from the sputa of many individuals, it is critical to differentiate active disease from commensal harboring of the organisms. A scheme to help with the proper diagnosis of pulmonary infection caused by NTM has been developed by the American Thoracic Society and is widely used. The bulk of nontuberculous mycobacterial disease in North America is due to M. kansasii, organisms of the M. avium complex (MAC), and M. abscessus. ... The Research Committee is grateful to the following physicians and their staff, without whose cooperation the study would not have been possible: Dr R M Abbasi, Bishop Auckland; Dr O Afolabi, N Tyneside; Dr A Alexander, Bath; Dr N Ali, Sutton in Ashfield; Dr M B Allen, Stoke on Trent; Dr G Anderson, Newport; Dr P B Anderson, Sheffield; Dr S Ansari, Southend; Dr J T Baker, Wrexham; Dr V P Balagopal, Walsall; Dr J Banks, Swansea; Dr R Banks, Tonbridge Wells; Dr J Barclay, Oldham; Dr A Bartoloni, Italy; Dr J R M Bateman, Derby; Dr M Benson, Oxford; Dr A M Bentley, Manchester; Dr R J Bibby, Blackpool; Dr D Boldy, Boston; Dr M Bone, Dudley; Dr J Bradley, Barnet; Dr R A L Brewis, Newcastle; Dr M Britton, Ashford; Dr P Brown, Perth; Dr A L Burton, Preston; Dr I A Campbell, Penarth; Dr S Cardellichio, Italy; Dr J Catterall, Bristol; Dr G Chappell, Bridgend; Dr D Chew, Chesterfield; Dr J Choo Kang, Kirkcaldy; Dr R Clark, Portsmouth; Dr C J Clarke, Glasgow; Dr D Clifton, Barnsely; Dr K Connolly, ...